Due to the popular demand, Pharma IQ has extended the nomination deadline for the Clinical Innovation Outsourcing Award for Dynamic Leadership in the Pharma and Biotech Industry.
The Clinical Outsourcing Innovation Awards 2012 has been designed to highlight key achievements made by individual companies within the R&D industry that have improved efficiencies and furthered the definition of innovation. The award will be reviewed for Dynamic Leadership in the Pharma and Biotech Industry.
The Award nominees will be judged by the following criteria:
- Impact to company, business or end user
- Novelty, pursuit of entrepreneurship and industry best practice
- Technical excellence, content, validity and applicability
- Excellence in efficiency or improvements (cost cutting, improvement docs, service levels, patient safety, reduced risk, streamlined processes, etc)
Online voting will open this March allowing the community at large to vote. Additionally, there will be onsite voting at the Global Clinical Outsourcing Forum.
The delegation will have the opportunity to review the nominees and cast their vote. The awards presentation will be at the end of the first day of the Global Clinical Outsourcing Forum.
To enter the orders, one has to complete the nomination form and send it, along with supplementary information to support the nomination to Nicola Ambler at nicola.ambler@iqpc.co.uk. The nomination form can be obtained from the website
The Clinical Innovation Outsourcing Award was designed as a part of the Global Clinical Outsourcing Forum, taking place 24-25 April, 2012 in Amsterdam. The event brings together 20 leading industry experts and is completely presentation free providing an interactive, discussion based forum for clinical outsourcing experts.
For more information about the event, please visit www.globalclinicaloutsourcing.com/NEWS, email: enquire@iqpc.co.uk or call +44 (0)20 7036 1300
Media contact: Joanna Checinska, +44 (0)20 7368 9421, joanna.checinska@iqpc.co.uk - Please contact for more information or images.